Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

Glucagon-like peptide-1 (GLP-1) and glucagon-like ... Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes?J ...

These drugs target a receptor located on the outside of cells, called the glucagon-like peptide 1 receptor (GLP-1R ... a 30% lower risk of dementia compared to those taking other anti-diabetes drugs ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

It’s prescribed, alongside dietary changes and exercise, to adults with type 2 diabetes to help improve blood sugar ... form of semaglutide (a glucagon-like peptide-1 [GLP-1] receptor agonist ...